Nasdaq Down From High: The Tech Stocks I’d Buy First Today
The Nasdaq down from high has created a disciplined buying moment for patient investors. This guide highlights five t...
Why Active Funds May Underperform Benchmarks discusses persistent headwinds, costs, and timing issues that hinder outperformance.
26,804 articlesThe Nasdaq down from high has created a disciplined buying moment for patient investors. This guide highlights five t...
A Brazilian fund made a sizable bet on MercadoLibre even as the stock slid over the past year. This article unpacks t...
Anthropic's IPO signals more than one company going public. It underscores a rising demand for AI compute, potentiall...
On a day when markets shuddered, TJX stood out as its shares rose. A mix of solid earnings signals, a supportive anal...
A looming recession can test your retirement plan. Discover three common mistakes to avoid, plus practical steps to s...
Bruker's Q1 2026 earnings transcript can reveal much about the stock's path in 2026. This guide breaks down what to l...
June 2026 brings a surprising shift: the market shows the strongest sign housing market signals in years. This articl...
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
If you’re curious whether tapping your home equity can fuel your next rental purchase, you’re not alone. This practic...
Institutional moves can reshape a niche tech stock overnight. This article breaks down the recent liquidation by Loun...
When a top executive sells stock, it sparks questions about the company’s prospects. This guide breaks down insider m...
2026 is shaping up as the year Nvidia investors reconsider. While the stock once led the market, it now trails the S&...